Aaron J. Oakley
Papers
1
Total Citations
62
H-Index
1
About
Aaron J. Oakley is a structural biologist whose work lies at the intersection of protein crystallography and drug discovery. His primary research focuses on fragment-based drug discovery (FBDD), a powerful approach that screens small, low-molecular-weight compounds against clinically relevant macromolecular targets. Oakley’s landmark 2012 review, “Fragment-Based Screening by Protein Crystallography: Successes and Pitfalls,” has garnered over 60 citations, serving as a critical guide for researchers navigating the complexities of this technique. In this work, he systematically dissects both the triumphs and the common methodological traps of crystallographic fragment screening, providing an essential roadmap for translating initial hits into viable drug leads. Beyond this influential review, Oakley’s contributions extend to understanding the structural biology of key proteins involved in disease, including those linked to antibiotic resistance and cancer. His work has been instrumental in advancing the practical application of structural data to rational drug design, making him a notable figure in the field. For students and researchers, Oakley’s research exemplifies how fundamental structural insights can be harnessed for tangible therapeutic impact.
Research Focus
Key Achievements
Top Papers
- 1Fragment-Based Screening by Protein Crystallography: Successes and Pitfalls62 citations · 2012